Scarica l'app Stockscreener
163.04
1.61%
-2.67
Dopo l'orario di chiusura:
163.04
Precedente Chiudi:
$165.71
Aprire:
$164.82
Volume 24 ore:
752.51K
Relative Volume:
0.55
Capitalizzazione di mercato:
$22.38B
Reddito:
$1.96B
Utile/perdita netta:
$-253.24M
Rapporto P/E:
-85.36
EPS:
-1.91
Flusso di cassa netto:
$94.06M
1 W Prestazione:
+1.49%
1M Prestazione:
+17.38%
6M Prestazione:
+4.11%
1 anno Prestazione:
+35.56%
Intervallo 1D:
$162.53
$166.57
Intervallo di 1 settimana:
$158.70
$168.52
Portata 52W:
$110.57
$183.00
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Confronta NTRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
163.04 | 22.74B | 1.96B | -253.24M | 94.06M | -1.91 |
|
TMO
Thermo Fisher Scientific Inc
|
488.12 | 184.46B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.00 | 147.69B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.86 | 51.34B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.69 | 33.60B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
188.80 | 31.92B | 15.70B | 1.24B | 2.01B | 6.91 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
What MACD signals say about Natera Inc.July 2025 Macro Moves & High Return Trade Opportunity Guides - Newser
What indicators show strength in Natera Inc.2025 Biggest Moves & Step-by-Step Swing Trade Plans - Newser
Natera Inc. Trading Near Value Zone — Recovery Ahead getLinesFromResByArray error: size == 0 - 더경남뉴스
Chart based analysis of Natera Inc. trendsInflation Watch & Risk Adjusted Swing Trade Ideas - Newser
Risk adjusted return profile for Natera Inc. analyzedChart Signals & Proven Capital Preservation Tips - Newser
Natera Shows Rising Relative Strength; Still Shy Of Key Benchmark - MSN
Tick level data insight on Natera Inc. volatilityMarket Risk Analysis & Risk Controlled Swing Alerts - Newser
Full technical analysis of Natera Inc. stock2025 Breakouts & Breakdowns & Precise Buy Zone Tips - Newser
Natera Inc.: An Insight Into Its Strategic Collaborations, AI Initiatives & Other Major Drivers! - Smartkarma
Should you wait for a breakout in Natera Inc.Risk Management & Daily Profit Maximizing Tips - Newser
Risk vs reward if holding onto Natera Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser
Intraday pattern recognizer results for Natera Inc.Trade Performance Summary & Low Drawdown Investment Ideas - Newser
Is Natera Inc. still worth holding after the dipPortfolio Performance Summary & AI Forecasted Entry/Exit Points - Newser
What data driven models say about Natera Inc.’s futureGDP Growth & Weekly Chart Analysis and Guides - Newser
Applying Wyckoff theory to Natera Inc. stockTrade Volume Summary & Weekly Stock Breakout Alerts - Newser
What to do if you’re stuck in Natera Inc.July 2025 PostEarnings & Verified Trade Idea Suggestions - Newser
How sentiment analysis helps forecast Natera Inc.Rate Cut & Fast Gain Swing Trade Alerts - Newser
Natera Inc. stock trend outlook and recovery pathShort Setup & Real-Time Chart Breakout Alerts - Newser
Can trapped investors hope for a rebound in Natera Inc.Index Update & Low Drawdown Trading Techniques - Newser
Guardant Drops Cancer Test Trade Secrets Suit Against Natera - Bloomberg Law News
Natera's AI Platform for Precision Oncology: A Game-Changer in Clinical Decision-Making and Patient Outcomes. - AInvest
Natera Shares Rise on the Launch of AI Platform for Precision Oncology - Yahoo Finance
Natera to Present Signatera™ Data at the IASLC World Conference on Lung Cancer - Business Wire
Sentiment analysis tools applied to Natera Inc.2025 Market WrapUp & Fast Momentum Stock Entry Tips - Newser
Intraday pattern recognizer results for Natera Inc2025 Historical Comparison & AI Enhanced Trading Signals - Newser
Leading vs lagging indicators on Natera Inc. performanceVolume Spike & Pattern Based Trade Signal System - Newser
Natera (NTRA): Assessing Valuation After AI Platform Launch and Positive Phase III Signatera Results - simplywall.st
Short Covering May Lift Natera Inc. in Near TermMarket Growth Summary & Weekly High Return Forecasts - 더경남뉴스
What moving averages say about Natera Inc.July 2025 Update & Daily Price Action Insights - Newser
Is Natera Inc. in a bullish channelJuly 2025 Final Week & Short-Term High Return Strategies - theviewers.co.kr
Is Natera Inc. stock a good dividend stockJuly 2025 Trade Ideas & Risk Controlled Stock Pick Alerts - 더경남뉴스
Natera Launches AI Foundation Models for Diagnostic and Therapeutic Advancements - AInvest
Natera Technology Featured in 300+ Peer-Reviewed Publications, Underscoring Scientific Leadership in Precision Medicine - Lelezard
Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation - 01net
Leap Therapeutics shares rise 3.27% premarket after Natera's AI foundation model launch. - AInvest
Natera's AI-Driven Precision Medicine Platform: A High-Conviction Bet on the Future of Personalized Cancer Care - AInvest
Offered a cash price for a prenatal genetic test? It may be your best bet - KUOW
Revolutionizing Biopharma: Natera's AI-Driven Precision Medicine Platform as a Catalyst for Drug Development and Investor Value - AInvest
Natera Bounces 0.32% on 37% Volume Surge as Stock Ranks 471st Amid Mixed Institutional Moves and Analyst Outlooks - AInvest
Non-Invasive Prenatal Screening Market 2025-2032: Advanced - openPR.com
CareDx gets $96M jury verdict overturned in Natera patent dispute - MSN
Natera says IMvigor011 bladder cancer trial achieves positive results - MSN
Natera (NTRA) Reports Positive Phase III Trial Results in Muscle-Invasive Bladder Cancer - simplywall.st
What technical models suggest about Natera Inc.’s comebackMarket Volume Report & Daily Entry Point Trade Alerts - Newser
Natera, Inc.IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera Strongly Predicting Adjuvant Immunotherapy Benefit - MarketScreener
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):